⌘+K

Pre-results note

We expect NPI and start-up costs to weigh on margins in Q4

Johan Wettergren

Jakob Söderblom

2026-01-12

09:18 CET

In Q4 2025 we expect Scanfil to have continued converting its strong order trend into manufacturing programmes, which we expect to bring with it higher costs related to production starts. This view is also reinforced by our belief that Scanfil initiated a higher share of Medtech & Life Science projects in Q4 than in past quarters, given the higher order intake (+89% Y/Y in Q3) and the stringent quality requirements that come with this segment. That said, we remain below Scanfil’s midpoint revenue and EBITA guidance for 2025, a view reinforced by completion of the MB Elettronica acquisition being postponed. We lower our fair value range to EUR7.7–12.2 (8.8–13.1) based on our updated estimates.

Expecting order normalisation following a blowout Q3. We model for Scanfil to report orders of EUR53m in Q4 2025, down 13% Y/Y, after having reported order growth of 73% Y/Y in Q3. Segment-wise, we remain optimistic about Energy & Cleantech demand, as well as continued solid sentiment within Medtech & Life Science. We forecast revenue of EUR226m in Q4 2025, supported by continued solid momentum within APAC, particularly the Americas. On the M&A front, Scanfil completed the acquisition of ADCO in December, and management expects the larger MB Elettronica acquisition to be closed in January 2026. We forecast adj. EBITA of EUR15.6m in Q4 2025, corresponding to a margin of 6.9% – down 10bps from Q4 2024.

NPI inflates opex in 2025; higher amortisation ahead. Ahead of the report release, our estimates are impacted by higher costs related to new project introductions in Q4, as well as higher amortisation related to M&A.

2025 was eventful; 2026 looks promising. 2025 was the year Scanfil reinitiated its M&A agenda in full fashion, announcing two large acquisitions in the Americas and Europe. Organic growth returned, and the efficiency measures undertaken in recent years also started to show results. However, with strong reported order intake, encouraging commentary around end-demand, and the inclusion of MB Elettronica, 2026 looks just as promising, we argue.

Key stats

About DNB Carnegie Access

DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

Private Banking

Tailored wealth management. Your financial future, personalized.

Montrose

A digital investment platform designed for passionate investors.

DNB Carnegie

Leading Nordic investment bank and wealth management.

© Copyright DNB Carnegie Investment Bank AB